EUVIMEDEUVIMED entdecken
Crossref

Three‐in‐One: Biomimetic Trimetallic Ionic‐Site Nanozyme Composite as a Redox Homeostasis Disruptor for Ferroptosis/Cuproptosis/Pyroptosis Co‐Activated Nanocatalytic Therapy

Lin-Jiao Yang, Yu-Ying Cai, Nefise Nurtay, Meng-Meng Pan, Chuanjie Zhang, Xuan Hu, Xi-Tian Peng, Yingxin Wei, Ming Jiang, Xiao-Wei Wu, Li Xu, Xu Yu iD

Small · 2025-12 · 21 (49)

DOI: 10.1002/smll.202509285 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, online erschienen am 22.10.2025. Verfasst von Lin-Jiao Yang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan, 430030, China. Hauptthemen laut MEDLINE: Homeostasis, Ferroptosis, Pyroptosis, Biomimetic Materials. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Program for HUST Academic Frontier Youth Team, CIRP Open Fund of Radiation Protection Laboratories.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Given the critical role of tumor redox homeostasis in sustaining malignant growth, simultaneously targeting multiple aspects of intracellular balance may offer a more efficient therapeutic strategy. Herein, a t rimetallic i onic‐ s ite nanozyme is engineered by integrating A u 3 ⁺, R u 3 ⁺, and C u 2 ⁺ ions into a nanoscale metal‐organic framework ( tis‐ARC ). The nanozyme is further loaded with gambogic acid (GA) and buthionine sulfoximine (BSO) and cloaked in tumor cell membranes (tis‐ARC‐GB@M) to enhance targeting and homologous recognition. The resulting tis‐ARC‐GB@M exhibited multi‐enzyme mimetic catalytic activities that disrupted tumor redox balance by simultaneously amplifying reactive oxygen species (ROS) production and depleting glutathione (GSH), thereby dismantling the tumor's intrinsic antioxidant defenses. This cascade of events triggered several cell death pathways‐including ferroptosis, cuproptosis, and pyroptosis, and released damage‐associated biomarker molecules that reprogrammed the tumor microenvironment (TME). Mechanistically, oxidative stress‐enhanced ferroptosis, cuproptosis, and pyroptosis collectively disrupted mitochondrial metabolism, which in turn exacerbated intracellular oxidative stress, resulting in a mutually reinforcing therapeutic effect. In vitro and in vivo studies demonstrated that tis‐ARC‐GB@M significantly suppressed tumor growth in tumor‐bearing models. Overall, this approach establishes a novel paradigm for antitumor nanocatalytic therapy through the targeted disruption of intracellular homeostasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HomeostasisFerroptosisPyroptosisBiomimetic MaterialsBiomimeticsOxidation-ReductionHumansAnimalsReactive Oxygen SpeciesCell Line, TumorMiceCatalysisGlutathioneMetal-Organic FrameworksOxidative Stress

Stichwörter der Autor:innen

cascade catalytic reactioncuproptosisferroptosispyroptosistrimetallic ionic site nanozyme

Substanzen

Reactive Oxygen SpeciesGlutathioneMetal-Organic Frameworks

Autor:innen und Institutionen

  • Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan, 430030, China.
  • Department of Thoracic Surgery, Tongji Hospital, Tongji Medical Collage, Huazhong University of Science and Technology, Wuhan, 430030, China.
  • Institute of Agricultural Quality Standards and Testing Technology Research, Hubei Academy of Agricultural Sciences, Wuhan, 430064, China.
  • Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100730, China.

ORCID-Profile: Xu Yu

Förderung

  • National Natural Science Foundation of China
  • Program for HUST Academic Frontier Youth Team
  • CIRP Open Fund of Radiation Protection Laboratories

Zitieren

APA

Yang, L. J., Cai, Y. Y., Nurtay, N., Pan, M. M., Zhang, C., Hu, X., Peng, X. T., Wei, Y., Jiang, M., Wu, X. W., Xu, L., & Yu, X. (2025). Three‐in‐One: Biomimetic Trimetallic Ionic‐Site Nanozyme Composite as a Redox Homeostasis Disruptor for Ferroptosis/Cuproptosis/Pyroptosis Co‐Activated Nanocatalytic Therapy. Small, 21(49). https://doi.org/10.1002/smll.202509285

Vancouver

Yang LJ, Cai YY, Nurtay N, Pan MM, Zhang C, Hu X, et al. Three‐in‐One: Biomimetic Trimetallic Ionic‐Site Nanozyme Composite as a Redox Homeostasis Disruptor for Ferroptosis/Cuproptosis/Pyroptosis Co‐Activated Nanocatalytic Therapy. Small. 2025;21(49). doi:10.1002/smll.202509285

BibTeX
@article{Yang2025,
  author = {Yang, Lin-Jiao and Cai, Yu-Ying and Nurtay, Nefise and Pan, Meng-Meng and Zhang, Chuanjie and Hu, Xuan and Peng, Xi-Tian and Wei, Yingxin and Jiang, Ming and Wu, Xiao-Wei and Xu, Li and Yu, Xu},
  title = {Three‐in‐One: Biomimetic Trimetallic Ionic‐Site Nanozyme Composite as a Redox Homeostasis Disruptor for Ferroptosis/Cuproptosis/Pyroptosis Co‐Activated Nanocatalytic Therapy},
  journal = {Small},
  year = {2025},
  volume = {21},
  number = {49},
  doi = {10.1002/smll.202509285}
}
Kostenlos starten →